- Home
- JXJT vs NTBL Comparison
JXJT vs NTBL Comparison
Compare JXJT & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXJT
- NTBL
- Stock Information
- Founded
- JXJT 2012
- NTBL 2000
- Country
- JXJT China
- NTBL United States
- Employees
- JXJT N/A
- NTBL N/A
- Industry
- JXJT Apparel
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- JXJT Consumer Staples
- NTBL Health Care
- Exchange
- JXJT Nasdaq
- NTBL Nasdaq
- Market Cap
- JXJT 11.5M
- NTBL 4.6M
- IPO Year
- JXJT 2012
- NTBL N/A
- Fundamental
- Price
- JXJT $1.57
- NTBL $0.25
- Analyst Decision
- JXJT
- NTBL Buy
- Analyst Count
- JXJT 0
- NTBL 2
- Target Price
- JXJT N/A
- NTBL $5.00
- AVG Volume (30 Days)
- JXJT 36.7K
- NTBL 8.1M
- Earning Date
- JXJT 11-01-2024
- NTBL 11-12-2024
- Dividend Yield
- JXJT N/A
- NTBL N/A
- EPS Growth
- JXJT N/A
- NTBL N/A
- EPS
- JXJT 0.48
- NTBL N/A
- Revenue
- JXJT $31,840,588.00
- NTBL $313,000.00
- Revenue This Year
- JXJT N/A
- NTBL N/A
- Revenue Next Year
- JXJT N/A
- NTBL N/A
- P/E Ratio
- JXJT $3.40
- NTBL N/A
- Revenue Growth
- JXJT N/A
- NTBL 3812.50
- 52 Week Low
- JXJT $1.04
- NTBL $0.22
- 52 Week High
- JXJT $8.51
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- JXJT 38.73
- NTBL 35.14
- Support Level
- JXJT $1.40
- NTBL $0.28
- Resistance Level
- JXJT $1.75
- NTBL $0.37
- Average True Range (ATR)
- JXJT 0.14
- NTBL 0.06
- MACD
- JXJT -0.04
- NTBL -0.01
- Stochastic Oscillator
- JXJT 32.08
- NTBL 6.26
About JXJT JX Luxventure Limited
JX Luxventure Ltd is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Airline tickets and tourism services, Software Solutions for Tourism Cross-border operation, and Tourism Cross-border Merchandise. The majority of the group revenue is generated from Tourism products.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.